{"podcast":{"title":"Nucleate Podcast","slug":"nucleate-podcast-6322042","podcast_index_feed_id":6322042,"rss_url":"https://feeds.simplecast.com/OdcQl6Pu","website_url":"https://nucleate-signal.simplecast.com","image_url":"https://image.simplecastcdn.com/images/ed52f7f3-cb55-48af-ae20-82bc5484ef83/a79cf5fe-a623-40da-8d8f-966d626b56de/3000x3000/youtube-20logo.jpg?aid=rss_feed","author":"Nucleate","episode_count":45,"summary":"Nucleate is the new voice for next generation biotech leaders.","last_synced_at":"2026-06-04T14:21:51.754137+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042"},"episodes":[{"title":"Leading Mission-Driven Biotechs | Jodie Morrison, CEO of Q32 Bio | Jodie Morrison, CEO of Q32 Bio","slug":"leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio","published_at":"2026-06-04T04:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio","url":"https://nucleate-signal.simplecast.com/episodes/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio-LPYba3d0","duration_seconds":3975,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/leading-mission-driven-biotechs-jodie-morrison-ceo-of-q32-bio-jodie-morrison-ceo-of-q32-bio.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From Genomics to Deal-Making: How Science Becomes a Company | Laurence Reid, Biotech Entrepreneur","slug":"from-genomics-to-deal-making-how-science-becomes-a-company-laurence-reid-biotech-entrepreneur","published_at":"2026-03-24T16:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/from-genomics-to-deal-making-how-science-becomes-a-company-laurence-reid-biotech-entrepreneur","url":"https://nucleate-signal.simplecast.com/episodes/from-genomics-to-deal-making-how-science-becomes-a-company-laurence-reid-biotech-entrepreneur-dWHaTSSv","duration_seconds":5782,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/from-genomics-to-deal-making-how-science-becomes-a-company-laurence-reid-biotech-entrepreneur/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/from-genomics-to-deal-making-how-science-becomes-a-company-laurence-reid-biotech-entrepreneur.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Negotiating Intellectual Property, Staying Focused, and Making the Most of Mentors with Michal Preminger, Board Member at MassBio","slug":"negotiating-intellectual-property-staying-focused-and-making-the-most-of-mentors-with-michal-preminger-board-member-at-massbio","published_at":"2026-03-10T04:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/negotiating-intellectual-property-staying-focused-and-making-the-most-of-mentors-with-michal-preminger-board-member-at-massbio","url":"https://nucleate-signal.simplecast.com/episodes/negotiating-intellectual-property-staying-focused-and-making-the-most-of-mentors-with-michal-preminger-board-member-at-massbio-Ug4HYwnI","duration_seconds":4052,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/negotiating-intellectual-property-staying-focused-and-making-the-most-of-mentors-with-michal-preminger-board-member-at-massbio/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/negotiating-intellectual-property-staying-focused-and-making-the-most-of-mentors-with-michal-preminger-board-member-at-massbio.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"How Turbine Accelerates Drug Discovery with AI Simulation | Szabi Nagy, CEO and Co-Founder of Turbine","slug":"how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine","published_at":"2026-02-24T05:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine","url":"https://nucleate-signal.simplecast.com/episodes/founders-lessons-in-building-impact-beyond-the-lab-szabi-nagy-ceo-and-co-founder-of-turbine-wF_lLnS9","duration_seconds":3400,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/how-turbine-accelerates-drug-discovery-with-ai-simulation-szabi-nagy-ceo-and-co-founder-of-turbine.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Science of Stem Cells and Social Impact: Inside Ovelle with Merrick Smela and Travis Potter","slug":"the-science-of-stem-cells-and-social-impact-inside-ovelle-with-merrick-smela-and-travis-potter","published_at":"2026-02-10T05:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-science-of-stem-cells-and-social-impact-inside-ovelle-with-merrick-smela-and-travis-potter","url":"https://nucleate-signal.simplecast.com/episodes/the-science-of-stem-cells-and-social-impact-inside-ovelle-with-merrick-smela-and-travis-potter-3qfyDGF_","duration_seconds":3017,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/the-science-of-stem-cells-and-social-impact-inside-ovelle-with-merrick-smela-and-travis-potter/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-science-of-stem-cells-and-social-impact-inside-ovelle-with-merrick-smela-and-travis-potter.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Inside TechBio Investing | Claire Smith, Partner at Springtide VC","slug":"inside-techbio-investing-claire-smith-partner-at-springtide-vc","published_at":"2026-01-27T05:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/inside-techbio-investing-claire-smith-partner-at-springtide-vc","url":"https://nucleate-signal.simplecast.com/episodes/inside-techbio-investing-claire-smith-partner-at-springtide-vc-3hjLEz5a","duration_seconds":3781,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/inside-techbio-investing-claire-smith-partner-at-springtide-vc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/inside-techbio-investing-claire-smith-partner-at-springtide-vc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Functional Precision Oncology, a new compass for cancer care | Apricot Bio","slug":"functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio","published_at":"2025-12-20T13:33:55+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio","url":"https://nucleate-signal.simplecast.com/episodes/functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio-mUidQkjf","duration_seconds":4980,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/functional-precision-oncology-a-new-compass-for-cancer-care-apricot-bio.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Art and Science of Drug Hunting | Christoph Lengauer, CSO & Co-Founder of Curie.bio","slug":"the-art-and-science-of-drug-hunting-christoph-lengauer-cso-co-founder-of-curie-bio","published_at":"2025-12-10T05:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-art-and-science-of-drug-hunting-christoph-lengauer-cso-co-founder-of-curie-bio","url":"https://nucleate-signal.simplecast.com/episodes/the-art-and-science-of-drug-hunting-christoph-lengauer-cso-co-founder-of-curiebio-WdNHyZm5","duration_seconds":4362,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/the-art-and-science-of-drug-hunting-christoph-lengauer-cso-co-founder-of-curie-bio/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-art-and-science-of-drug-hunting-christoph-lengauer-cso-co-founder-of-curie-bio.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"⁠Blackjack, Biosecurity and Big Bets | Alexander Titus, National Biotech Commissioner","slug":"blackjack-biosecurity-and-big-bets-alexander-titus-national-biotech-commissioner","published_at":"2025-11-21T05:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/blackjack-biosecurity-and-big-bets-alexander-titus-national-biotech-commissioner","url":"https://nucleate-signal.simplecast.com/episodes/doing-hard-things-with-good-people-alexander-titus-national-biotech-commissioner-6vrOUpB7","duration_seconds":4069,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/blackjack-biosecurity-and-big-bets-alexander-titus-national-biotech-commissioner/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/blackjack-biosecurity-and-big-bets-alexander-titus-national-biotech-commissioner.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The Science of Saving Millions | Mikael Dolsten, Fmr. CSO of Pfizer","slug":"the-science-of-saving-millions-mikael-dolsten-fmr-cso-of-pfizer","published_at":"2025-11-06T05:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-science-of-saving-millions-mikael-dolsten-fmr-cso-of-pfizer","url":"https://nucleate-signal.simplecast.com/episodes/the-science-of-saving-millions-mikael-dolsten-fmr-cso-of-pfizer-HV0VQzDu","duration_seconds":5379,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/the-science-of-saving-millions-mikael-dolsten-fmr-cso-of-pfizer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-science-of-saving-millions-mikael-dolsten-fmr-cso-of-pfizer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"What it Takes to Build a $50B Biotech Moonshot | John Maraganore, Founding CEO of Alnylam Therapeutics","slug":"what-it-takes-to-build-a-50b-biotech-moonshot-john-maraganore-founding-ceo-of-alnylam-therapeutics","published_at":"2025-10-23T04:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/what-it-takes-to-build-a-50b-biotech-moonshot-john-maraganore-founding-ceo-of-alnylam-therapeutics","url":"https://nucleate-signal.simplecast.com/episodes/what-it-takes-to-build-a-50b-biotech-moonshot-john-maraganore-co-founder-of-alnylam-therapeutics-C2IOzGnO","duration_seconds":3755,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/what-it-takes-to-build-a-50b-biotech-moonshot-john-maraganore-founding-ceo-of-alnylam-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/what-it-takes-to-build-a-50b-biotech-moonshot-john-maraganore-founding-ceo-of-alnylam-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Heartbreak to Hope: A Mother’s Mission to Cure Angelman Syndrome | Dr Allyson Berent, CSO of FAST","slug":"heartbreak-to-hope-a-mother-s-mission-to-cure-angelman-syndrome-dr-allyson-berent-cso-of-fast","published_at":"2025-10-06T04:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/heartbreak-to-hope-a-mother-s-mission-to-cure-angelman-syndrome-dr-allyson-berent-cso-of-fast","url":"https://nucleate-signal.simplecast.com/episodes/heartbreak-to-hope-a-mothers-mission-to-cure-angelman-syndrome-dr-allyson-berent-csooffast-rM2pqRPp","duration_seconds":4348,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/heartbreak-to-hope-a-mother-s-mission-to-cure-angelman-syndrome-dr-allyson-berent-cso-of-fast/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/heartbreak-to-hope-a-mother-s-mission-to-cure-angelman-syndrome-dr-allyson-berent-cso-of-fast.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Decoding the Future: Data, AI, and Biotech with Joe Horsman, Madrona Ventures","slug":"decoding-the-future-data-ai-and-biotech-with-joe-horsman-madrona-ventures","published_at":"2025-09-18T10:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/decoding-the-future-data-ai-and-biotech-with-joe-horsman-madrona-ventures","url":"https://nucleate-signal.simplecast.com/episodes/decoding-the-future-data-ai-and-biotech-with-joe-horsman-madrona-ventures-XPNV4XAE","duration_seconds":4983,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/decoding-the-future-data-ai-and-biotech-with-joe-horsman-madrona-ventures/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/decoding-the-future-data-ai-and-biotech-with-joe-horsman-madrona-ventures.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"When board turns, but mission stays | Armon Sharei, Founder & CEO at Portal on Resilience in Biotech","slug":"when-board-turns-but-mission-stays-armon-sharei-founder-ceo-at-portal-on-resilience-in-biotech","published_at":"2025-09-11T07:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/when-board-turns-but-mission-stays-armon-sharei-founder-ceo-at-portal-on-resilience-in-biotech","url":"https://nucleate-signal.simplecast.com/episodes/when-board-turns-but-mission-stays-armon-sharei-founder-ceo-at-portal-on-resilience-in-biotech-sroOL_M3","duration_seconds":4221,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/when-board-turns-but-mission-stays-armon-sharei-founder-ceo-at-portal-on-resilience-in-biotech/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/when-board-turns-but-mission-stays-armon-sharei-founder-ceo-at-portal-on-resilience-in-biotech.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The 10% mindset and power of bold ideas | Prof. Dr. Dominik Ruettinger, Global Head Oncology R&D, Bayer Pharmaceuticals","slug":"the-10-mindset-and-power-of-bold-ideas-prof-dr-dominik-ruettinger-global-head-oncology-r-d-bayer-pharmaceuticals","published_at":"2025-08-14T01:53:14+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-10-mindset-and-power-of-bold-ideas-prof-dr-dominik-ruettinger-global-head-oncology-r-d-bayer-pharmaceuticals","url":"https://nucleate-signal.simplecast.com/episodes/the-10-mindset-and-power-of-bold-ideas-prof-dr-dominik-ruettinger-global-head-oncology-rd-bayer-pharmaceuticals-CxgcuUld","duration_seconds":3791,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/the-10-mindset-and-power-of-bold-ideas-prof-dr-dominik-ruettinger-global-head-oncology-r-d-bayer-pharmaceuticals/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-10-mindset-and-power-of-bold-ideas-prof-dr-dominik-ruettinger-global-head-oncology-r-d-bayer-pharmaceuticals.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Startups are hard, do something that matters | Armand Cognetta, CEO & founder General Proximity","slug":"startups-are-hard-do-something-that-matters-armand-cognetta-ceo-founder-general-proximity","published_at":"2025-07-10T23:47:51+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/startups-are-hard-do-something-that-matters-armand-cognetta-ceo-founder-general-proximity","url":"https://nucleate-signal.simplecast.com/episodes/startups-are-hard-do-something-that-matters-armand-cognetta-ceo-founder-general-proximity-EkzTY8Fi","duration_seconds":4757,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/startups-are-hard-do-something-that-matters-armand-cognetta-ceo-founder-general-proximity/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/startups-are-hard-do-something-that-matters-armand-cognetta-ceo-founder-general-proximity.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"From science to startup: real talk on biotech founding paths | Hilary Schulz and Dr. Willliam Heath, Persephoni BioPartners","slug":"from-science-to-startup-real-talk-on-biotech-founding-paths-hilary-schulz-and-dr-willliam-heath-persephoni-biopartners","published_at":"2025-06-27T03:19:55+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/from-science-to-startup-real-talk-on-biotech-founding-paths-hilary-schulz-and-dr-willliam-heath-persephoni-biopartners","url":"https://nucleate-signal.simplecast.com/episodes/what-happens-after-nucleate-the-playbook-for-biotech-builders-hilary-schulz-and-dr-willliam-health-persephoni-biopartners-vNaJO2uq","duration_seconds":4548,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/from-science-to-startup-real-talk-on-biotech-founding-paths-hilary-schulz-and-dr-willliam-heath-persephoni-biopartners/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/from-science-to-startup-real-talk-on-biotech-founding-paths-hilary-schulz-and-dr-willliam-heath-persephoni-biopartners.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Breakthrough: The stories behind Life-Changing Therapies | Dr. William Pao former CDO of Pfizer","slug":"breakthrough-the-stories-behind-life-changing-therapies-dr-william-pao-former-cdo-of-pfizer","published_at":"2025-06-11T04:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/breakthrough-the-stories-behind-life-changing-therapies-dr-william-pao-former-cdo-of-pfizer","url":"https://nucleate-signal.simplecast.com/episodes/breakthrough-the-stories-behind-life-changing-therapies-with-dr-william-pao-JOSynYeQ","duration_seconds":4628,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/breakthrough-the-stories-behind-life-changing-therapies-dr-william-pao-former-cdo-of-pfizer/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/breakthrough-the-stories-behind-life-changing-therapies-dr-william-pao-former-cdo-of-pfizer.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Turning Genomic Insights into Breakthrough Therapies | Peter Campbell, CSO of Quotient Therapeutics","slug":"turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics","published_at":"2025-05-28T10:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics","url":"https://nucleate-signal.simplecast.com/episodes/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics-FVozM2mz","duration_seconds":4764,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/turning-genomic-insights-into-breakthrough-therapies-peter-campbell-cso-of-quotient-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Building Biotech: From the Lab to the Boardroom | Raj Devraj, CEO of Rectify Pharma","slug":"building-biotech-from-the-lab-to-the-boardroom-raj-devraj-ceo-of-rectify-pharma","published_at":"2025-05-14T10:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/building-biotech-from-the-lab-to-the-boardroom-raj-devraj-ceo-of-rectify-pharma","url":"https://nucleate-signal.simplecast.com/episodes/building-biotech-from-the-lab-to-the-boardroom-raj-devraj-ceo-of-rectify-pharma-1fzGfCB4","duration_seconds":4620,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/building-biotech-from-the-lab-to-the-boardroom-raj-devraj-ceo-of-rectify-pharma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/building-biotech-from-the-lab-to-the-boardroom-raj-devraj-ceo-of-rectify-pharma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"The unsolved frontier: making the undruggable druggable | Eswar Iyer, Aikium","slug":"the-unsolved-frontier-making-the-undruggable-druggable-eswar-iyer-aikium","published_at":"2025-04-30T13:58:16+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-unsolved-frontier-making-the-undruggable-druggable-eswar-iyer-aikium","url":"https://nucleate-signal.simplecast.com/episodes/the-unsolved-frontier-making-the-undruggable-druggable-eswar-iyer-aikium-juuJ3rIa","duration_seconds":4634,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/the-unsolved-frontier-making-the-undruggable-druggable-eswar-iyer-aikium/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/the-unsolved-frontier-making-the-undruggable-druggable-eswar-iyer-aikium.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Reinventing R&D: collaboration for tomorrow’s therapies | Dr. Uli Stilz, BIH at Novo Nordisk","slug":"reinventing-r-d-collaboration-for-tomorrow-s-therapies-dr-uli-stilz-bih-at-novo-nordisk","published_at":"2025-04-17T18:05:50+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/reinventing-r-d-collaboration-for-tomorrow-s-therapies-dr-uli-stilz-bih-at-novo-nordisk","url":"https://nucleate-signal.simplecast.com/episodes/reinventing-rd-collaboration-for-tomorrows-therapies-dr-uli-stilz-bih-at-novo-nordisk-kCOVAAkE","duration_seconds":3292,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/reinventing-r-d-collaboration-for-tomorrow-s-therapies-dr-uli-stilz-bih-at-novo-nordisk/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/reinventing-r-d-collaboration-for-tomorrow-s-therapies-dr-uli-stilz-bih-at-novo-nordisk.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"If you’re not too early, you’re too late | Shelby Newsad, Partner at Compound VC","slug":"if-you-re-not-too-early-you-re-too-late-shelby-newsad-partner-at-compound-vc","published_at":"2025-04-10T22:28:44+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/if-you-re-not-too-early-you-re-too-late-shelby-newsad-partner-at-compound-vc","url":"https://nucleate-signal.simplecast.com/episodes/if-youre-not-too-early-youre-too-late-shelby-newsad-partner-at-compound-vc-rdk_ywwI","duration_seconds":2940,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/if-you-re-not-too-early-you-re-too-late-shelby-newsad-partner-at-compound-vc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/if-you-re-not-too-early-you-re-too-late-shelby-newsad-partner-at-compound-vc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Go start your company today: Dave Messina, GP Pioneer Fund","slug":"go-start-your-company-today-dave-messina-gp-pioneer-fund","published_at":"2025-04-03T10:00:00+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/go-start-your-company-today-dave-messina-gp-pioneer-fund","url":"https://nucleate-signal.simplecast.com/episodes/go-start-your-company-today-dave-messina-gp-pioneer-fund-6tccdZsN","duration_seconds":4674,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/go-start-your-company-today-dave-messina-gp-pioneer-fund/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/go-start-your-company-today-dave-messina-gp-pioneer-fund.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Empowering Future Biotech Leaders | Dr. Michelle Hoffmann, CBC","slug":"empowering-future-biotech-leaders-dr-michelle-hoffmann-cbc","published_at":"2025-03-19T11:46:08+00:00","page_url":"https://stenobird.com/podcast/nucleate-podcast-6322042/empowering-future-biotech-leaders-dr-michelle-hoffmann-cbc","url":"https://nucleate-signal.simplecast.com/episodes/empowering-future-biotech-leaders-dr-michelle-hoffmann-cbc-qXc9I8LC","duration_seconds":4593,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/nucleate-podcast-6322042/episodes/empowering-future-biotech-leaders-dr-michelle-hoffmann-cbc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/nucleate-podcast-6322042/empowering-future-biotech-leaders-dr-michelle-hoffmann-cbc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}